Quantitative cytology as facilitated by flow cytometry is an essential tool of cancer researchers. The objective of the Flow Cytometry Shared Resource (FCSR) is, therefore, to provide cost-effective and state-of-the-art cell analysis and cell sorting instrumentation and services in support of the basic, translational, and clinical cancer research activities of Virginia Commonwealth University (VCU) Massey Cancer Center (MCC) members and the MCC research programs. The FCSR additionally provides instrumentation and services in support of surface plasmon resonance (SPR), a sensitive method for the label-free determination of the selectivity and affinity of interactions between diverse biological molecules. The FCSR supports this mission by maintaining 6 major instruments?2 advanced multi-laser cell sorters, 2 multi-laser cell analyzers, an advanced imaging cytometer, and a dual-channel SPR instrument. The resource is directed by Daniel Conrad, PhD, and is supported by 2 FTEs. The resource director and/or staff support MCC programmatic science by providing: consultative services for experimental design and data interpretation; education to certify end-users in the use of the equipment; operator-assisted cell sorting, cell analysis, and SPR; method development; and instrument maintenance. All FCSR services are located in a single central location within easy walking distance of MCC. The FCSR is a jointly managed (MCC and VCU) resource, and standard hours for the facility are 8 AM until 6 PM, Monday through Friday. Trained and certified users have access to the facility 24 hours per day, 7 days per week. Equipment time and technician-assisted activities are tracked and charged back. The services provided by the FCSR add significant value for MCC-member research, as the nature of these services (often involving live cells) requires that they be available locally, and they would in any case be cost prohibitive if sourced from a commercial provider. The work supported by the FCSR continues to have a positive impact on cancer research by allowing MCC members to pursue their research objectives in a cost-effective and efficient manner. Indeed, in CY2015 FCSR supported the research of 38 MCC members (representing 58% of the total user base). MCC-member usage came from representatives of all 4 MCC research programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016059-37
Application #
9483639
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
37
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Li, Xiaojiaoyang; Liu, Runping; Huang, Zhiming et al. (2018) Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans. Hepatology 68:599-615
Durant, Stephen T; Zheng, Li; Wang, Yingchun et al. (2018) The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Sci Adv 4:eaat1719
Damle, S R; Martin, R K; Cockburn, C L et al. (2018) ADAM10 and Notch1 on murine dendritic cells control the development of type 2 immunity and IgE production. Allergy 73:125-136
Wang, Feng; Li, Hongyan; Markovsky, Ela et al. (2018) Pazopanib radio-sensitization of human sarcoma tumors. Oncotarget 9:9311-9324
Stokes, Nancy A; Stanciu, Cristina E; Brocato, Emily R et al. (2018) Simplification of complex DNA profiles using front end cell separation and probabilistic modeling. Forensic Sci Int Genet 36:205-212
Poklepovic, Andrew; Qu, Yuesheng; Dickinson, Molly et al. (2018) Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers. Cardiooncology 4:
Karlin, Jeremy; Allen, Jasmine; Ahmad, Syed F et al. (2018) Orally Bioavailable and Blood-Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice. Mol Cancer Ther 17:1637-1647
Robertson, Chadia L; Mendoza, Rachel G; Jariwala, Nidhi et al. (2018) Astrocyte Elevated Gene-1 Regulates Macrophage Activation in Hepatocellular Carcinogenesis. Cancer Res 78:6436-6446
Kazarian, Elizabeth; Son, HyunYoung; Sapao, Paulene et al. (2018) SPAG17 Is Required for Male Germ Cell Differentiation and Fertility. Int J Mol Sci 19:
Farrell, Nicholas P; Gorle, Anil K; Peterson, Erica J et al. (2018) Metalloglycomics. Met Ions Life Sci 18:

Showing the most recent 10 out of 586 publications